Niharika Sharma

Principal at Roivant Sciences

Dr. Niharika Sharma is a Principal embedded within the Corporate Development team based in Basel, Switzerland. She is focussed on external partnerships and internal acquisitions/divestitures. Previously as an Investment Associate at Roivant, she spearheaded European Asset Search and Evaluation efforts spanning the entire spectrum of clinical development in a therapeutic area agnostic manner. Prior to this, she was a part of Roivant’s Analyst program leading multiple projects ranging from clinical research to commercial due diligence for several vants such as Enzyvant, Immunovant and Axovant.

She holds a PhD in Immunology from Hannover Medical School, Germany and Karolinska Institute, Sweden, a M.Sc. in Immunology from King’s College London and B.Sc. in Biotechnology from Manipal School of Life Sciences, India.